XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues:        
Revenues $ 5,648 $ 7,141 $ 10,736 $ 13,646
Costs and expenses:        
Cost of goods sold 1,196 1,126 2,197 2,083
Research and development expenses 1,192 864 2,129 1,795
Selling, general and administrative expenses 980 897 1,977 1,747
Total costs and expenses 3,368 2,887 6,303 5,625
Income from operations 2,280 4,254 4,433 8,021
Interest expense (266) (269) (556) (530)
Other income (expense), net 72 130 242 241
Income before provision for income taxes 2,086 4,115 4,119 7,732
Provision for income taxes 267 1,046 761 1,964
Net income 1,819 3,069 3,358 5,768
Net income (loss) attributable to noncontrolling interest 2 (4) 3 (7)
Net income attributable to Gilead $ 1,817 $ 3,073 $ 3,355 $ 5,775
Net income per share attributable to Gilead common stockholders - basic (usd per share) $ 1.40 $ 2.35 $ 2.58 $ 4.42
Shares used in per share calculation - basic (in shares) 1,298 1,307 1,302 1,307
Net income per share attributable to Gilead common stockholders - diluted (usd per share) $ 1.39 $ 2.33 $ 2.55 $ 4.38
Shares used in per share calculation - diluted (in shares) 1,308 1,317 1,314 1,319
Cash dividends declared (usd per share) $ 0.57 $ 0.52 $ 1.14 $ 1.04
Product sales        
Revenues:        
Product revenue $ 5,540 $ 7,046 $ 10,541 $ 13,423
Royalty, contract and other revenues        
Revenues:        
Revenues $ 108 $ 95 $ 195 $ 223